Browser does not support script.
We make a powerful contribution to understanding how genetic abnormalities within cancer cells lead to disease. Through Birmingham’s Cancer Research UK Clinical Trials Unit- one of Europe’s leading clinical trials unit- we use this information to design and rigorously assess new and proven cancer treatments. In so doing, we will play a significant role in accelerating the ultimate control of cancer.
Sudha Sundar has been elected as the first female president of the British Gynaecological Society
Pam Kearns achieved her goal of cycling 175 miles across England to raise money for cancer
Professor Ulrich Gunther succeeded in his bid for a 1 GHz NMR spectrometer
Scientists win award to tackle hard to treat cancers
Life Sciences in Six - Dr Joanna Parish
My story: Graham Silk
Posted 17 October 2018
A recently-approved breast cancer drug could be used to target and treat a life-threatening leukaemia, new research has revealed.
Posted 28 August 2018
Matt Hancock, Secretary of State for Health and Social Care, met Cancer Research UK-funded scientists at the University of Birmingham today (Thursday, 23 August) to learn about their life-saving work.
Posted 21 August 2018
The University of Birmingham women's cancer expert, Dr Sudha Sundar, has been chosen as the President-Elect of the British Gynaecological Cancer Society (BGCS), the first female gynaecological oncologist to be elected to this post.
View all news